HCPLive Network

Functional MRI Can Improve Prediction of Cognitive Behavioral Therapy Success

 
FRIDAY, Jan. 4 (HealthDay News) -- Results of functional brain imaging can greatly improve prediction of which patients with social anxiety disorder (SAD) will benefit from cognitive behavioral therapy (CBT), according to a study published in the January issue of JAMA Psychiatry.

Oliver Doehrmann, Ph.D., from the Massachusetts Institute of Technology in Cambridge, and colleagues examined brain responses to angry versus neutral faces or emotional versus neutral scenes using functional magnetic resonance imaging (MRI). This functional MRI data was collected prior to a CBT intervention to predict subsequent response to treatment in 39 medication-free patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for the generalized subtype of SAD. Changes in the Liebowitz Social Anxiety Scale score were measured to assess treatment outcome.

The researchers found that pretreatment responses significantly predicted the subsequent treatment outcome of patients selectively for social stimuli and particularly in regions of higher-order visual cortex. Clinical severity measures combined with the brain measures accounted for more than 40 percent of the variance in treatment response. Using brain measures greatly exceeded predictions based on clinical measures alone at baseline. Potential confounding factors such as depression severity at baseline did not affect prediction success.

"The results suggest that brain imaging can provide biomarkers that substantially improve predictions for the success of cognitive behavioral interventions and more generally suggest that such biomarkers may offer evidence-based, personalized medicine approaches for optimally selecting among treatment options for a patient," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 

Further Reading
Atherosclerotic internal carotid artery disease is a major contributor to ischemic stroke. Surgeons use a combination of carotid artery and brain imaging to determine if patients have symptomatic carotid stenosis. However, there remains widespread disagreement on the threshold, timing, and best technical approach to carotid revascularization in symptomatic patients.
The FDA has cleared a blood test that can screen patients, especially black women, for coronary heart disease.
The chemical compound indazole chloride (Ind-Cl) initiated long lasting relief in mice models of multiple sclerosis.
More Reading